Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering

International Journal of Molecular Sciences

Volumn 14, Issue 1, 2013, Pages 1629-1654

  Nitta, Sachiko Kaihara ^a   Numata, Keiji ^a  

^a Enzyme Research Team   (Japan)

Author keywords

Biodegradable polymer; Biopolymer; Drug delivery; Gene delivery; Nanoparticle

Indexed keywords

ALBUMIN; ALGINIC ACID; ARGINYLGLYCYLASPARTIC ACID; ASPARAGINASE; BETA CASEIN; BIOMATERIAL; BIOPOLYMER; CHITOSAN; CISPLATIN; COLLAGEN; ELASTIN; FLUOROURACIL; GELATIN; GLUTARALDEHYDE; HEPARIN; HYPOCRELLIN B; INSULIN; LYSOZYME; MACROGOL; MITOXANTRONE; NANOCARRIER; NANOPARTICLE; PACLITAXEL; POLYETHYLENEIMINE; POLYSACCHARIDE; PULLULAN; SILK; STARCH; UNINDEXED DRUG; ZEIN;

BIOCOMPATIBILITY; BIODEGRADABILITY; BLADDER CANCER; BREAST CANCER; COACERVATION; CROSS LINKING; DIABETES MELLITUS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; ENCAPSULATION; GENE DELIVERY SYSTEM; HUMAN; HYDROGEL; IMMUNOGENICITY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR WEIGHT; MORPHOLOGY; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; REVIEW; SURFACE CHARGE; TENSILE STRENGTH; TISSUE ENGINEERING; YOUNG MODULUS; CHEMISTRY; GENE TRANSFER; PROCEDURES; TRENDS;

BIOCOMPATIBLE MATERIALS; BIOPOLYMERS; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; TISSUE ENGINEERING;

EID: 84877801388     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14011629     Document Type: Review

References (175)

1. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55, 329-347.
2. Kataoka, K.; Harada, A.; Nagasaki, Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv. Drug Deliv. Rev. 2012, 64, 37-48.
3. Shi, J.; Votruba, A.R.; Farokhzad, O.C.; Langer, R. Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano. Lett. 2010, 10, 3223-3230.
4. Mironov, V.; Kasyanov, V.; Markwald, R.R. Nanotechnology in vascular tissue engineering: from nanoscaffolding towards rapid vessel biofabrication. Trends Biotechnol. 2008, 26, 338-344.
5. Koo, O.M.; Rubinstein, I.; Onyuksel, H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomed. Nanotechnol. Biol. Med. 2005, 1, 193-212.
6. Wang, X.; Yang, L.; Chen, Z.; Shin, D.M. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin. 2008, 58, 97-110.
7. Hansma, H.G. Surface biology of DNA by atomic force microscopy. Annu. Rev. Phys. Chem. 2001, 52, 71-92.
8. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 2012, 64, 24-36.
9. Basarkar, A.; Singh, J. Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice. Pharm. Res. 2009, 26, 72-81.
10. Roy, K.; Mao, H.-Q.; Huang, S.K.; Leong, K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 1999, 5, 387-391.
11. Furno, F.; Morley, K.S.; Wong, B.; Sharp, B.L.; Arnold, P.L.; Howdle, S.M.; Bayston, R.; Brown, P.D.; Winship, P.D.; Reid, H.J. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J. Antimicrob. Chemother. 2004, 54, 1019-1024.
12. Wilson, D.S.; Dalmasso, G.; Wang, L.; Sitaraman, S.V.; Merlin, D.; Murthy, N. Orally delivered thioketal nanoparticles loaded with TNF-a-siRNA target inflammation and inhibit gene expression in the intestines. Nat. Mater. 2010, 9, 923-928.
13. Yu, D.-G.; Lin, W.-C.; Yang, M.-C. Surface modification of poly(l-lactic acid) membrane via layer-by-layer assembly of silver nanoparticle-embedded polyelectrolyte multilayer. Bioconjug. Chem. 2007, 18, 1521-1529.
14. Heiati, H.; Phillips, N.; Tawashi, R. Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride. Pharm. Res. 1996, 13, 1406-1410.
15. Yang, Y.-Y.; Wang, Y.; Powell, R.; Chan, P. Polymeric core-shell nanoparticles for therapeutics. Clin. Exp. Pharmacol. Physiol. 2006, 33, 557-562.
16. Yih, T.C.; Al-Fandi, M. Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 2006, 97, 1184-1190.
17. Hamidi, M.; Azadi, A.; Rafiei, P. Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev. 2008, 60, 1638-1649.
18. Elzoghby, A.O.; Samy, W.M.; Elgindy, N.A. Protein-based nanocarriers as promising drug and gene delivery systems. J. Control. Release 2012, 161, 38-49.
19. Mizrahy, S.; Peer, D. Polysaccharides as building blocks for nanotherapeutics. Chem. Soc. Rev. 2012, 41, 2623-2640.
20. Donaldson, K.; Stone, V.; Tran, C.L.; Kreyling, W.; Borm, P.J.A. Nanotoxicology. Occup. Environ. Med. 2004, 61, 727-728.
21. Moghimi, S.M.; Hunter, A.C.; Murray, J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharm. Rev. 2001, 53, 283-318.
22. Adiseshaiah, P.P.; Hall, J.B.; McNeil, S.E. Nanomaterial standards for efficacy and toxicity assessment. Wiley Interdiscip. Rev. 2010, 2, 99-112.
23. Gaumet, M.; Vargas, A.; Gurny, R.; Delie, F. Nanoparticles for drug delivery: The need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 2008, 69, 1-9.
24. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 2000, 65, 271-284.
25. Hirano, A.; Kawanami, T.; Llena, J.F. Electron microscopy of the blood-brain barrier in disease. Microsc. Res. Tech. 1994, 27, 543-556.
26. Hobbs, S.K.; Monsky, W.L.; Yuan, F.; Roberts, W.G.; Griffith, L.; Torchilin, V.P.; Jain, R.K. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Nat. Acad. Sci. USA 1998, 95, 4607-4612.
27. Nakaoka, R.; Tabata, Y.; Yamaoka, T.; Ikada, Y. Prolongation of the serum half-life period of superoxide dismutase by poly(ethylene glycol) modification. J. Control. Release 1997, 46, 253-261.
28. Moghimi, S.M. Mechanisms of splenic clearance of blood cells and particles: Towards development of new splenotropic agents. Adv. Drug Deliv. Rev. 1995, 17, 103-115.
29. Petros, R.A.; DeSimone, J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 2010, 9, 615-627.
30. Mohanraj, V.; Chen, Y. Nanoparticles-A Review. Tropical J. Pharm. Res. 2006, 5, 561-573.
31. Mansouri, S.; Lavigne, P.; Corsi, K.; Benderdour, M.; Beaumont, E.; Fernandes, J.C. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur. J. Pharm. Biopharm. 2004, 57, 1-8.
32. Thomas, M.; Klibanov, A.M. Non-viral gene therapy: Polycation-mediated DNA delivery. Appl. Microbiol. Biotechnol. 2003, 62, 27-34.
33. Li, S.D.; Huang, L. Gene therapy progress and prospects: Non-viral gene therapy by systemic delivery. Gene Ther. 2006, 13, 1313-1319.
34. Dang, J.M.; Leong, K.W. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 2006, 58, 487-499.
35. Weller, R.B. Nitric oxide-containing nanoparticles as an antimicrobial agent and enhancer of wound healing. J. Invest. Dermatol. 2009, 129, 2335-2337.
36. Carpenter, A.W.; Schoenfisch, M.H. Nitric oxide release: Part II. Therapeutic applications. Chem. Soc. Rev. 2012, 41, 3742-3752.
37. Eroy-Reveles, A.A.; Mascharak, P.K. Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery. Future Med. Chem. 2009, 1, 1497-1507.
38. Friedman, A.J.; Han, G.; Navati, M.S.; Chacko, M.; Gunther, L.; Alfieri, A.; Friedman, J.M. Sustained release nitric oxide releasing nanoparticles: Characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 2008, 19, 12-20.
39. Goldberg, M.; Langer, R.; Jia, X. Nanostructured materials for applications in drug delivery and tissue engineering. J. Biomater. Sci. Polym. Ed. 2007, 18, 241-268.
40. Peng, L.; Cheng, X.; Zhuo, R.; Lan, J.; Wang, Y.; Shi, B.; Li, S. Novel gene-activated matrix with embedded chitosan/plasmid DNA nanoparticles encoding PDGF for periodontal tissue engineering. J. Biomed. Mater. Res. Part A 2009, 90A, 564-576.
41. Ghuman, J.; Zunszain, P.A.; Petitpas, I.; Bhattacharya, A.A.; Otagiri, M.; Curry, S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 2005, 353, 38-52.
42. Koch-Weser, J.; Sellers, E.M. Binding of drugs to serum albumin. N. Engl. J. Med. 1976, 294, 526-531.
43. Desai, N.; Trieu, V.; Yao, Z.; Louie, L.; Ci, S.; Yang, A.; Tao, C.; De, T.; Beals, B.; Dykes, D.; et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin. Cancer Res. 2006, 12, 1317-1324.
44. Vuignier, K.; Schappler, J.; Veuthey, J.-L.; Carrupt, P.-A.; Martel, S. Drug-protein binding: a critical review of analytical tools. Anal. Bioanal. Chem. 2010, 398, 53-66.
45. Chen, L.; Remondetto, G.E.; Subirade, M. Food protein-based materials as nutraceutical delivery systems. Trends Food Sci. Technol.2006, 17, 272-283.
46. Elzoghby, A.O.; Abo El-Fotoh, W.S.; Elgindy, N.A. Casein-based formulations as promising controlled release drug delivery systems. J. Control. Release 2011, 153, 206-216.
47. Elzoghby, A.O.; Samy, W.M.; Elgindy, N.A. Albumin-based nanoparticles as potential controlled release drug delivery systems. J. Control. Release 2012, 157, 168-182.
48. Parenteau-Bareil, R.; Gauvin, R.; Berthod, F. Collagen-based biomaterials for tissue engineering applications. Materials 2010, 3, 1863-1887.
49. Friess, W. Collagen-biomaterial for drug delivery. Eur. J. Pharm. Biopharm. 1998, 45, 113-136.
50. Daamen, W.F.; Veerkamp, J.H.; van Hest, J.C.M.; van Kuppevelt, T.H. Elastin as a biomaterial for tissue engineering. Biomaterials 2007, 28, 4378-4398.
51. Doillon, C.J.; Silver, F.H.; Berg, R.A. Fibroblast growth on a porous collagen sponge containing hyaluronic acid and fibronectin. Biomaterials 1987, 8, 195-200.
52. Meyer, D.E.; Chilkoti, A. Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: Examples from the elastin-like polypeptide system. Biomacromolecules 2002, 3, 357-367.
53. Sun, G.; Hsueh, P.-Y.; Janib, S.M.; Hamm-Alvarez, S.; Andrew MacKay, J. Design and cellular internalization of genetically engineered polypeptide nanoparticles displaying adenovirus knob domain. J. Control. Release 2011, 155, 218-226.
54. Chilkoti, A.; Dreher, M.R.; Meyer, D.E. Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv. Drug Deliv. Rev. 2002, 54, 1093-1111.
55. Biman, B.M.; Kundu, S.C. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery. Nanotechnology 2009, 20, 355101.
56. Lammel, A.S.; Hu, X.; Park, S.-H.; Kaplan, D.L.; Scheibel, T.R. Controlling silk fibroin particle features for drug delivery. Biomaterials 2010, 31, 4583-4591.
57. Bunschoten, A.; Buckle, T.; Kuil, J.; Luker, G.D.; Luker, K.E.; Nieweg, O.E.; van Leeuwen, F.W.B. Targeted non-covalent self-assembled nanoparticles based on human serum albumin. Biomaterials 2012, 33, 867-875.
58. Kratz, F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 2008, 132, 171-183.
59. Papi, M.; Palmieri, V.; Maulucci, G.; Arcovito, G.; Greco, E.; Quintiliani, G.; Fraziano, M.; de Spirito, M. Controlled self assembly of collagen nanoparticle. J. Nanopart. Res. 2011, 13, 6141-6147.
60. Rössler, B.; Kreuter, J.; Scherer, D. Collagen microparticles: Preparation and properties. J. Microencapsul. 1995, 12, 49-57.
61. Numata, K.; Kaplan, D.L. Silk-based delivery systems of bioactive molecules. Adv. Drug Deliv. Rev. 2010, 62, 1497-1508.
62. Kundu, J.; Chung, Y.-I.; Kim, Y.H.; Tae, G.; Kundu, S.C. Silk fibroin nanoparticles for cellular uptake and control release. Int. J. Pharm. 2010, 388, 242-250.
63. Gupta, V.; Aseh, A.; Rios, C.N.; Aggarwal, B.B.; Mathur, A.B. Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int. J. Nanomed. 2009, 4, 115-122.
64. Yan, H.-B.; Zhang, Y.-Q.; Ma, Y.-L.; Zhou, L.-X. Biosynthesis of insulin-silk fibroin nanoparticles conjugates and in vitro evaluation of a drug delivery system. J. Nanopart. Res. 2009, 11, 1937-1946.
65. Zhang, Y.-Q.; Wang, Y.-J.; Wang, H.-Y.; Zhu, L.; Zhou, Z.-Z. Highly efficient processing of silk fibroin nanoparticle-l-asparaginase bioconjugates and their characterization as a drug delivery system. Soft Matter 2011, 7, 9728-9736.
66. Numata, K.; Yamazaki, S.; Naga, N. Biocompatible and biodegradable dual-drug release system based on silk hydrogel containing silk nanoparticles. Biomacromolecules 2012, 13, 1383-1389.
67. Numata, K.; Hamasaki, J.; Subramanian, B.; Kaplan, D.L. Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs. J. Control. Release 2010, 146, 136-143.
68. Numata, K.; Kaplan, D.L. Silk-based gene carriers with cell membrane destabilizing peptides. Biomacromolecules 2010, 11, 3189-3195.
69. Numata, K.; Reagan, M.R.; Goldstein, R.H.; Rosenblatt, M.; Kaplan, D.L. Spider silk-based gene carriers for tumor cell-specific delivery. Bioconjug. Chem. 2011, 22, 1605-1610.
70. Numata, K.; Subramanian, B.; Currie, H.A.; Kaplan, D.L. Bioengineered silk protein-based gene delivery systems. Biomaterials 2009, 30, 5775-5784.
71. Maeda, M.; Tani, S.; Sano, A.; Fujioka, K. Microstructure and release characteristics of the minipellet, a collagen-based drug delivery system for controlled release of protein drugs. J. Control. Release 1999, 62, 313-324.
72. Marty, J.J.; Oppenheim, R.C.; Speiser, P. Nanoparticles-a new colloidal drug delivery system. Pharm. Act. Helvetiae. 1978, 53, 17-23.
73. Coesters, C.J.; von Briesen, K.L.H.; Kreuter, J. Gelatin nanoparticles by two step desolvation a new preparation method, surface modifications and cell uptake. J. Microencapsul. 2000, 17, 187-193.
74. Sailaja, A.K.; Amareshwar, P. Preparation of gelatine nanoparticles by desolvation technique using acetone as desolvating agent. J. Pharm. Res. 2012, 5, 1854-1856.
75. Zhao, Y.-Z.; Li, X.; Lu, C.-T.; Xu, Y.-Y.; Lv, H.-F.; Dai, D.-D.; Zhang, L.; Sun, C.-Z.; Yang, W.; Li, X.-K.; et al. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy. Acta Diabetologica. 2012, 49, 315-325.
76. Kuo, W.-T.; Huang, H.-Y.; Chou, M.-J.; Wu, M.-C.; Huang, Y.-Y. Surface modification of gelatin nanoparticles with polyethylenimine as gene vector. J. Nanomater. 2011, 2011, 1-5.
77. Leo, E.; Angela Vandelli, M.; Cameroni, R.; Forni, F. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process. Int. J. Pharm. 1997, 155, 75-82.
78. Lee, E.; Khan, S.; Park, J.; Lim, K.-H. Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation. Bioprocess. Biosyst. Eng. 2012, 35, 297-307.
79. Gan, Z.; Ju, J.; Zhang, T.; Wu, D. Preparation of rhodamine B fluorescent poly(methacrylic acid) coated gelatin nanoparticles. J. Nanomater. 2011, 2011, doi:10.1155/2011/753705.
80. Li, W.-M.; Liu, D.-M.; Chen, S.-Y. Amphiphilically-modified gelatin nanoparticles: Self-assembly behavior, controlled biodegradability, and rapid cellular uptake for intracellular drug delivery. J. Mater. Chem. 2011, 21, 12381-12388.
81. Babu, A.; Jeyasubramanian, K.; Gunasekaran, P.; Murugesan, R. Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model. J. Biomed. Nanotechnol. 2012, 8, 43-56.
82. Jain, A.; Gulbake, A.; Jain, A.; Shilpi, S.; Hurkat, P.; Jain, A.; Jain, S.K. Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumour targeting. J. Microencapsul. 2012, 29, 95-102.
83. Lu, Z.; Yeh, T.-K.; Wang, J.; Chen, L.; Lyness, G.; Xin, Y.; Wientjes, M.G.; Bergdall, V.; Couto, G.; Alvarez-Berger, F.; et al. Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy. J. Urol. 2011, 185, 1478-1483.
84. Horne, D.S. Casein structure, self-assembly and gelation. Curr. Opin. Colloid Interface Sci. 2002, 7, 456-461.
85. Portnaya, I.; Cogan, U.; Livney, Y.D.; Ramon, O.; Shimoni, K.; Rosenberg, M.; Danino, D. Micellization of bovine ß-casein studied by isothermal titration microcalorimetry and cryogenic transmission electron microscopy. J. Agric. Food Chem. 2006, 54, 5555-5561.
86. Huppertz, T.; de Kruif, C.G. Structure and stability of nanogel particles prepared by internal cross-linking of casein micelles. Int. Dairy J. 2008, 18, 556-565.
87. Smiddy, M.A.; Martin, J.E.G.H.; Kelly, A.L.; de Kruif, C.G.; Huppertz, T. Stability of casein micelles cross-linked by transglutaminase. J. Dairy Sci. 2006, 89, 1906-1914.
88. Kamiya, N.; Shiotari, Y.; Tokunaga, M.; Matsunaga, H.; Yamanouchi, H.; Nakano, K.; Goto, M. Stimuli-responsive nanoparticles composed of naturally occurring amphiphilic proteins. Chem. Commun. 2009, doi:10.1039/B909897F.
89. Pan, X.; Yu, S.; Yao, P.; Shao, Z. Self-assembly of ß-casein and lysozyme. J. Colloid Interface Sci. 2007, 316, 405-412.
90. Shapira, A.; Davidson, I.; Avni, N.; Assaraf, Y.G.; Livney, Y.D. ß-Casein nanoparticle-based oral drug delivery system for potential treatment of gastric carcinoma: Stability, target-activated release and cytotoxicity. Eur. J. Pharm. Biopharm. 2012, 80, 298-305.
91. Shapira, A.; Assaraf, Y.G.; Livney, Y.D. Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs. Nanomed. Nanotechnol. Biol. Med. 2010, 6, 119-126.
92. Lai, L.F.; Guo, H.X. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. Int. J. Pharm. 2011, 404, 317-323.
93. Zhong, Q.; Tian, H.; Zivanovic, S. Encapsulation of fish oil in solid zein particles by liquid-liquid dispersion. J. Food Process. Preserv. 2009, 33, 255-270.
94. Zhong, Q.; Jin, M. Zein nanoparticles produced by liquid-liquid dispersion. Food Hydrocolloids 2009, 23, 2380-2387.
95. Podaralla, S.; Perumal, O. Preparation of zein nanoparticles by pH controlled nanoprecipitation. J. Biomed. Nanotechnol. 2010, 6, 312-317.
96. Ravindran Girija, A.; Balasubramanian, S.; Dhandayudhapani, B.; Takahiro, F.; Yasuhiko, Y.; Toru, M.; Kumar, D.S. Biocompatible fluorescent zein nanoparticles for simultaneous bioimaging and drug delivery application. Adv. Nat. Sci. 2012, 3, 025006.
97. Xu, H.; Jiang, Q.; Reddy, N.; Yang, Y. Hollow nanoparticles from zein for potential medical applications. J. Mater. Chem. 2011, 21, 18227-18235.
98. Steinhauser, I.M.; Langer, K.; Strebhardt, K.M.; Spänkuch, B. Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation. Biomaterials 2008, 29, 4022-4028.
99. Park, K. Albumin: A versatile carrier for drug delivery. J. Control. Release 2012, 157, 3.
100. Elsadek, B.; Kratz, F. Impact of albumin on drug delivery-New applications on the horizon. J. Control. Release 2012, 157, 4-28.
101. Bosse, D.; Praus, M.; Kiessling, P.; Nyman, L.; Andresen, C.; Waters, J.; Schindel, F. Phase I comparability of recombinant human albumin and human serum albumin. J. Clin. Pharmacol. 2005, 45, 57-67.
102. Hedayati, R.; Jahanshahi, M.; Attar, H. Fabrication and characterization of albumin-acacia nanoparticles based on complex coacervation as potent nanocarrier. J. Chem. Technol. Biotechnol. 2012, 87, 1401-1408.
103. Weber, C.; Coester, C.; Kreuter, J.; Langer, K. Desolvation process and surface characterisation of protein nanoparticles. Int. J. Pharm. 2000, 194, 91-102.
104. Mehravar, R.; Saghatoleslami, N. Fabrication and evaluation of human serum albumin (HSA) nanoparticles for drug delivery application. Int. J. Nanosci. 2009, 8, doi:10.1142/S0219581X09006080.
105. Müller, B.G.; Leuenberger, H.; Kissel, T. Albumin nanospheres as carriers for passive drug targeting: An optimized manufacturing technique. Pharm. Res. 1996, 13, 32-37.
106. Langer, K.; Balthasar, S.; Vogel, V.; Dinauer, N.; von Briesen, H.; Schubert, D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int. J. Pharm. 2003, 257, 169-180.
107. Weber, C.; Reiss, S.; Langer, K. Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups. Int. J. Pharm. 2000, 211, 67-78.
108. Martínez, A.; Benito-Miguel, M.; Iglesias, I.; Teijón, J.M.; Blanco, M.D. Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems. J. Biomed. Mater. Res. Part A 2012, 100A, 1467-1476.
109. Yu, S.; Yao, P.; Jiang, M.; Zhang, G. Nanogels prepared by self-assembly of oppositely charged globular proteins. Biopolymers 2006, 83, 148-158.
110. Wang, C.H.; Damodaran, S. Thermal gelation of globular proteins: Influence of protein conformation on gel strength. J. Agric. Food Chem. 1991, 39, 433-438.
111. Xu, R.; Fisher, M.; Juliano, R.L. Targeted albumin-based nanoparticles for delivery of amphipathic drugs. Bioconjug. Chem. 2011, 22, 870-878.
112. Gong, G.; Xu, Y.; Zhou, Y.; Meng, Z.; Ren, G.; Zhao, Y.; Zhang, X.; Wu, J.; Hu, Y. Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image. Biomacromolecules 2011, 13, 23-28.
113. Karmali, P.P.; Kotamraju, V.R.; Kastantin, M.; Black, M.; Missirlis, D.; Tirrell, M.; Ruoslahti, E. Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomed. Nanotechnol. Biol. Med. 2009, 5, 73-82.
114. Wright, E.R.; Conticello, V.P. Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences. Adv. Drug Deliv. Rev. 2002, 54, 1057-1073.
115. Lee, T.A.T.; Cooper, A.; Apkarian, R.P.; Conticello, V.P. Thermo-reversible self-assembly of nanoparticles derived from elastin-mimetic polypeptides. Adv. Mater. 2000, 12, 1105-1110.
116. Callahan, D.J.; Liu, W.; Li, X.; Dreher, M.R.; Hassouneh, W.; Kim, M.; Marszalek, P.; Chilkoti, A. Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution. Nano. Lett. 2012, 12, 2165-2170.
117. MacEwan, S.R.; Chilkoti, A. Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake. Nano Lett. 2012, 12, 3322-3328.
118. Osborne, J.L.; Farmer, R.; Woodhouse, K.A. Self-assembled elastin-like polypeptide particles. Acta Biomater. 2008, 4, 49-57.
119. Herrero-Vanrell, R.; Rincón, A.C.; Alonso, M.; Reboto, V.; Molina-Martinez, I.T.; Rodríguez-Cabello, J.C. Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release. J. Control. Release 2005, 102, 113-122.
120. Xia, X.-X.; Xu, Q.; Hu, X.; Qin, G.; Kaplan, D.L. Tunable self-assembly of genetically engineered silk-elastin-like protein polymers. Biomacromolecules 2011, 12, 3844-3850.
121. Oyarzun-Ampuero, F.A.; Goycoolea, F.M.; Torres, D.; Alonso, M.J. A new drug nanocarrier consisting of polyarginine and hyaluronic acid. Eur. J. Pharm. Biopharm. 2011, 79, 54-57.
122. Rodríguez-Hernández, J.; Lecommandoux, S. Reversible inside-out micellization of pH-responsive and water-soluble vesicles based on polypeptide diblock copolymers. J. Am. Chem. Soc. 2005, 127, 2026-2027.
123. Bhaw-Luximon, A. Modified Natural Polysaccharides as Nanoparticulate Drug Delivery Devices. In Engineered Carbohydrate-based Materials for Biomedical Applications; John Wiley & Sons, Inc.: Berlin, Germany, 2011; pp. 355-395.
124. Boddohi, S.; Moore, N.; Johnson, P.A.; Kipper, M.J. Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan. Biomacromolecules 2009, 10, 1402-1409.
125. Liu, Z.; Jiao, Y.; Wang, Y.; Zhou, C.; Zhang, Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev. 2008, 60, 1650-1662.
126. Saravanakumar, G.; Jo, D.G.; Park, J.H. Polysaccharide-Based Nanoparticles: A Versatile Platform for Drug Delivery and Biomedical Imaging. Curr. Med. Chem. 2012, 19, 3212-3229.
127. Aider, M. Chitosan application for active bio-based films production and potential in the food industry: Review. LWT Food Sci. Technol. 2010, 43, 837-842.
128. Schmitt, C.; Sanchez, C.; Desobry-Banon, S.; Hardy, J. Structure and Technofunctional Properties of Protein-Polysaccharide Complexes: A Review. Critical Rev. Food Sci. Nutr. 1998, 38, 689-753.
129. Roldo, M.; Hornof, M.; Caliceti, P.; Bernkop-Schnürch, A. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: Synthesis and in vitro evaluation. Eur. J. Pharm. Biopharm. 2004, 57, 115-121.
130. Sarmento, B.; Ribeiro, A.J.; Veiga, F.; Ferreira, D.C.; Neufeld, R.J. Insulin-Loaded Nanoparticles are Prepared by Alginate Ionotropic Pre-Gelation Followed by Chitosan Polyelectrolyte Complexation. J. Nanosci. Nanotechnol. 2007, 7, 2833-2841.
131. Rajam, M.; Pulavendran, S.; Rose, C.; Mandal, A.B. Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications. Int. J. Pharm. 2011, 410, 145-152.
132. George, M.; Abraham, T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan-A review. J. Control. Release 2006, 114, 1-14.
133. Douglas, K.L.; Piccirillo, C.A.; Tabrizian, M. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles. J. Control. Release 2006, 115, 354-361.
134. Reis, C.P.; Ribeiro, A.J.; Houng, S.; Veiga, F.; Neufeld, R.J. Nanoparticulate delivery system for insulin: Design, characterization and in vitro/in vivo bioactivity. Eur. J. Pharm. Sci. 2007, 30, 392-397.
135. You, J.-O.; Peng, C.-A. Calcium-Alginate Nanoparticles Formed by Reverse Microemulsion as gene carriers. Macromol. Symp.2005, 219, 147-153.
136. Berger, J.; Reist, M.; Mayer, J.M.; Felt, O.; Gurny, R. Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur. J. Pharm. Biopharm. 2004, 57, 35-52.
137. Liu, H.; Chen, B.; Mao, Z.; Gao, C. Chitosan nanoparticles for loading of toothpaste actives and adhesion on tooth analogs. J. Appl. Polym. Sci. 2007, 106, 4248-4256.
138. Bodnar, M.; Hartmann, J.F.; Borbely, J. Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 2005, 6, 2521-2527.
139. Janes, K.A.; Calvo, P.; Alonso, M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 2001, 47, 83-97.
140. Kaihara, S.; Suzuki, Y.; Fujimoto, K. In situ synthesis of polysaccharide nanoparticles via polyion complex of carboxymethyl cellulose and chitosan. Colloids Surfaces B 2011, 85, 343-348.
141. Sarmah, J.K.; Mahanta, R.; Bhattacharjee, S.K.; Mahanta, R.; Biswas, A. Controlled release of tamoxifen citrate encapsulated in cross-linked guar gum nanoparticles. Int. J. Biol. Macromol. 2011, 49, 390-396.
142. Xu, Y.; Du, Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm. 2003, 250, 215-226.
143. Csaba, N.; Köping-Höggård, M.; Alonso, M.J. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int. J. Pharm. 2009, 382, 205-214.
144. De Campos, A.M.; Sánchez, A.; Alonso, M.A.J. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm. 2001, 224, 159-168.
145. Peniche, H.; Peniche, C. Chitosan nanoparticles: a contribution to nanomedicine. Polym. Int. 2011, 60, 883-889.
146. Cui, Z.; Mumper, R.J. Chitosan-based nanoparticles for topical genetic immunization. J. Control. Release 2001, 75, 409-419.
147. Lin, Y.-H.; Chang, C.-H.; Wu, Y.-S.; Hsu, Y.-M.; Chiou, S.-F.; Chen, Y.-J. Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy. Biomaterials 2009, 30, 3332-3342.
148. Fuente, M.D.L.; Seijo, B.; Alonso, M.J. Design of novel polysaccharidic nanostructures for gene delivery. Nanotechnology 2008, 19, 075105.
149. Rodrigues, S.; Costa, A.M.R.D.; Grenha, A. Chitosan/carrageenan nanoparticles: Effect of cross-linking with tripolyphosphate and charge ratios. Carbohydr. Polym. 2012, 89, 282-289.
150. Gonçalves, N.P.; Oliveira, H.; Pêgo, A.P.; Saraiva, M.J. A novel nanoparticle delivery system for in vivo targeting of the sciatic nerve: impact on regeneration. Nanomedicine 2012, 7, 1167-1180.
151. Ammar, H.; El-Nahhas, S.; Ghorab, M.; Salama, A. Chitosan/cyclodextrin nanoparticles as drug delivery system. J. Inclusion Phenom. Macrocyc. Chem. 2012, 72, 127-136.
152. Giannotti, M.I.; Esteban, O.; Oliva, M.; García-Parajo, M.A.F.; Sanz, F. pH-Responsive polysaccharide-based polyelectrolyte complexes as nanocarriers for lysosomal delivery of therapeutic proteins. Biomacromolecules 2011, 12, 2524-2533.
153. Sonaje, K.; Lin, Y.-H.; Juang, J.-H.; Wey, S.-P.; Chen, C.-T.; Sung, H.-W. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 2009, 30, 2329-2339.
154. Bozkir, A.; Saka, O.M. Chitosan Nanoparticles for Plasmid DNA Delivery: Effect of Chitosan Molecular Structure on Formulation and Release Characteristics. Drug Deliv. 2004, 11, 107-112.
155. Hassani, L.N.; Hendra, F.; Bouchemal, K. Auto-associative amphiphilic polysaccharides as drug delivery systems. Drug Discov. Today 2012, 17, 608-614.
156. Chen, S.; Cheng, S.-X.; Zhuo, R.-X. Self-Assembly Strategy for the Preparation of Polymer-Based Nanoparticles for Drug and Gene Delivery. Macromol. Biosci. 2011, 11, 576-589.
157. Akiyoshi, K.; Kobayashi, S.; Shichibe, S.; Mix, D.; Baudys, M.; Wan Kim, S.; Sunamoto, J. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. J. Control. Release 1998, 54, 313-320.
158. Park, K.; Kim, K.; Kwon, I.C.; Kim, S.K.; Lee, S.; Lee, D.Y.; Byun, Y. Preparation and Characterization of Self-Assembled Nanoparticles of Heparin-Deoxycholic Acid Conjugates. Langmuir 2004, 20, 11726-11731.
159. Vauthier, C.; Bouchemal, K. Methods for the Preparation and Manufacture of Polymeric Nanoparticles. Pharm. Res. 2009, 26, 1025-1058.
160. Lee, K.Y.; Kwon, I.C.; Kim, Y.H.; Jo, W.H.; Jeong, S.Y. Preparation of chitosan self-aggregates as a gene delivery system. J. Control. Release 1998, 51, 213-220.
161. Mourya, V.K.; Inamdar, N.N. Chitosan-modifications and applications: Opportunities galore. React. Funct. Polym. 2008, 68, 1013-1051.
162. Nichifor, M.; Lopes, A.; Carpov, A.; Melo, E. Aggregation in Water of Dextran Hydrophobically Modified with Bile Acids. Macromolecules 1999, 32, 7078-7085.
163. Cui, L.; Cohen, J.A.; Broaders, K.E.; Beaudette, T.T.; Fréchet, J.M.J. Mannosylated Dextran Nanoparticles: A pH-Sensitive System Engineered for Immunomodulation through Mannose Targeting. Bioconjug. Chem. 2011, 22, 949-957.
164. Tang, M.; Dou, H.; Sun, K. One-step synthesis of dextran-based stable nanoparticles assisted by self-assembly. Polymer 2006, 47, 728-734.
165. Dou, H.; Tang, M.; Yang, W.; Sun, K. One-pot synthesis, characterization, and drug loading of polysaccharide-based nanoparticles with carboxy functional groups. Colloid Polym. Sci. 2007, 285, 1043-1047.
166. Wang, H.; Roman, M. Formation and Properties of Chitosan-Cellulose Nanocrystal Polyelectrolyte-Macroion omplexes for Drug Delivery pplications. Biomacromolecules 2011, 12, 1585-1593.
167. Choi, K.Y.; Chung, H.; Min, K.H.; Yoon, H.Y.; Kim, K.; Park, J.H.; Kwon, I.C.; Jeong, S.Y. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010, 31, 106-114.
168. Upadhyay, K.K.; Bhatt, A.N.; Mishra, A.K.; Dwarakanath, B.S.; Jain, S.; Schatz, C.; Le Meins, J.-F.; Farooque, A.; Chandraiah, G.; Jain, A.K.; et al. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(.-benzyl L-glutamate)-b-hyaluronan polymersomes. Biomaterials 2010, 31, 2882-2892.
169. Lee, S.J.; Hong, G.-Y.; Jeong, Y.-I.; Kang, M.-S.; Oh, J.-S.; Song, C.-E.; Lee, H.C. Paclitaxel-incorporated nanoparticles of hydrophobized polysaccharide and their antitumor activity. Int. J. Pharm. 2012, 433, 121-128.
170. Rodrigues, A.; Emeje, M. Recent applications of starch derivatives in nanodrug delivery. Carbohydr. Polym. 2012, 87, 987-994.
171. Le Corre, D.B.; Bras, J.; Dufresne, A. Starch Nanoparticles: A Review. Biomacromolecules 2010, 11, 1139-1153.
172. Santander-Ortega, M.J.; Stauner, T.; Loretz, B.; Ortega-Vinuesa, J.L.; Bastos-González, D.; Wenz, G.; Schaefer, U.F.; Lehr, C.M. Nanoparticles made from novel starch derivatives for transdermal drug delivery. J. Control. Release 2010, 141, 85-92.
173. Yu, D.; Xiao, S.; Tong, C.; Chen, L.; Liu, X. Dialdehyde starch nanoparticles: Preparation and application in drug carrier. Chin. Sci. Bull. 2007, 52, 2913-2918.
174. Dandekar, P.; Jain, R.; Stauner, T.; Loretz, B.; Koch, M.; Wenz, G.; Lehr, C.-M. A Hydrophobic Starch Polymer for Nanoparticle-Mediated Delivery of Docetaxel. Macromol. Biosci. 2012, 12, 184-194.
175. Li, L.; Kim, J.K.; Huh, K.M.; Lee, Y.-K.; Kim, S.Y. Targeted delivery of paclitaxel using folate-conjugated heparin-poly(ß-benzyl-L-aspartate) self-assembled nanoparticles. Carbohydr. Polym. 2012, 87, 2120-2128.